Withings launches Body Pro 3 for GLP-1 care in homes
Wed, 18th Nov 2026 (Today)
Withings Health Solutions has launched Body Pro 3, a cellular-connected health station for weight management programmes. The device is aimed at healthcare providers monitoring patients, including those receiving GLP-1 treatment.
The product is designed to give care teams more information than weight alone during home-based treatment. It combines segmental body composition readings, predictive modelling based on previous treatment journeys, and a hypertension risk notification feature that is subject to regulatory clearance.
Interest in more detailed monitoring has grown alongside wider use of GLP-1 medicines for obesity and weight loss. Healthcare providers are paying closer attention to changes in fat and muscle mass as patients lose weight, particularly because lean mass can also decline during treatment.
A review published in Acta Diabetologica found that about a quarter of weight lost during GLP-1 treatment can come from lean mass. Separately, a study in JAMA Network Open involving 125,474 adults in the United States with overweight or obesity found that about 65% of those without type 2 diabetes stopped treatment within a year.
Body Pro 3 is intended for healthcare organisations, remote patient monitoring providers, and clinical weight management programmes. It sends data automatically after each weigh-in without requiring Wi-Fi or Bluetooth pairing, then makes the information available through existing clinical systems.
Three functions
The first is segmental body composition tracking. Using a retractable handle, the device estimates fat and muscle mass for each arm, each leg, and the torso, and also provides a visceral fat index.
According to Withings, a validation study against DEXA found a correlation of 0.99 for fat mass and 0.98 for lean and muscle mass. DEXA is commonly used as a reference method in body composition assessment.
The second feature is a predictive model built from data drawn from tens of thousands of GLP-1 treatment journeys. It estimates future changes in weight, fat mass, and muscle mass from routine weigh-ins, and feeds into what Withings calls a Goal Probability Score and Off-Track Alerts.
The third function is a hypertension notification feature. It analyses weigh-in data to identify patterns that may suggest hypertension and prompt further clinical evaluation, but it does not measure blood pressure and is not a substitute for conventional blood pressure monitoring.
Provider focus
The launch points to a broader effort by digital health companies to move more clinical monitoring into patients' homes while keeping healthcare teams informed between appointments. Rather than relying on intermittent clinic visits, providers are increasingly seeking continuous or routine data flows that can show whether a care plan is staying on course.
Antoine Pivron, Vice President of Withings Health Solutions, said the rise of GLP-1 treatment had changed the demands on weight management programmes.
"GLP-1s are driving the biggest shift in weight care in decades, and programmes now face two hurdles: maintaining muscle and keeping members engaged," Pivron said.
"Body Pro 3 addresses both, showing care teams where each member's progress is heading so they can step in at the right moment, without asking members to do anything new."
Withings is positioning the device as a tool for routine use rather than a specialist assessment instrument limited to clinical settings. That reflects a wider push in remote care to gather more sophisticated measurements from patients at home while limiting setup or extra steps that might reduce adherence.
Withings also cited the prevalence of undiagnosed hypertension as part of the rationale for adding the notification function. According to the World Health Organisation, 44% of adults with hypertension worldwide are unaware they have the condition.
A healthcare professional at obesity clinic Yazen said the more detailed readout could support treatment decisions.
"As a nurse, I want to see more than a single number. This is the most accurate body composition results I've seen from a home scale, and the zone-by-zone breakdown shows whether a care plan is working well or needs adjustment," said Tobias Olsson, Clinic Support Manager and Registered Nurse at Yazen.
Body Pro 3 will be available in early 2027 for healthcare organisations, remote patient monitoring providers, and clinical weight management programmes.